Alzheimer’s Disease Drugs Market 2017 – Outlook Trends, Growth Factors, Top Manufacturers Regional Analysis and Forecasts to 2021
Precisemarketreports.com adds new report “Global Alzheimer’s Disease Drugs Market, Regional Analysis & Forecast, Major Deals & Funding, and Pipeline Drugs Analysis to 2021” which contains global key player’s survey information and forecast to 2022.
(EMAILWIRE.COM, December 05, 2017 ) Overview of the Global Alzheimer’s Disease Drugs Market:
The report spread across 189 pages is an overview of the Global Alzheimer’s Disease Drugs Market, Regional Analysis & Forecast, Major Deals & Funding, and Pipeline Drugs Analysis to 2021. Alzheimer’s disease is the most common cause of dementia among older people. It is a devastating condition for those afflicted as well as their family members and caregivers; the situation is only getting worse as the population ages. With the ageing global population, the number of patients suffering from Alzheimer’s disease is predicted to grow during the forecasting period. Alzheimer's treatment is a high risk, high reward market. Drugs currently available in the market have reached maturity; patent of leading drugs have expired. The current unmet needs represent a huge opportunity for pharmaceutical companies which are developing targeted novel therapies.
Get a Sample Copy of this Report @
https://www.precisemarketreports.com/report/sample/pmr-106497 .
Global Alzheimer’s disease Drugs Market and Pipeline Drugs Analysis:
• In 2016, the global market for Alzheimer’s disease drugs was dominated by Namenda, Memary, Aricept and Exelon. The combined market share of these four drugs was over 80% in the year 2016.
• Ebixa, Razadyne/Reminyl, Rivastach and Nootropil are the other popular drugs in the Alzheimer’s disease market.
• With the patent expiration of popular drugs the sales of the Alzheimer’s drugs have also declined. However, there are several pipeline drugs like Gantenerumab, Crenezumab and Aducanumab among others which are likely to hit the market during the period 2019 - 2020.
Global Alzheimer’s Disease Country Wise Analysis:
• In the Alzheimer’s disease drugs market, the United States is the largest market.
• The EU5 countries together accounted for over 10% share of the global Alzheimer’s disease drugs market in 2016.
To Purchase this report visit @
https://www.precisemarketreports.com/paypal/checkout/pmr-106497 .
The Alzheimer’s Disease Drugs Market has been analyzed from 8 View Points:
1. Alzheimer’s Disease - Drugs Sales and Forecast
2. Alzheimer’s Disease - Pipeline Drugs Sales Forecast
3. Alzheimer’s Disease Drugs - Country Wise Market and Forecast
4. Alzheimer’s Disease - Country Wise Prevalence and Forecast
5. Alzheimer’s Disease – List of Pipeline Drugs in Various Phase of Development
6. Alzheimer’s Disease - Major Deals in Alzheimer’s Drugs Market
7. Alzheimer’s Disease - Funding in Alzheimer’s Disease Research
8. Alzheimer’s Disease Drugs Market – Driving Factors & Challenges
The Top 9 Alzheimer’s Disease Drugs covered in the report are as follows:
1. Exelon
2. Razadyne/Reminyl
3. Memary
4. Ebixa
5. Aricept
6. Rivastach
7. Namenda
8. Nootropil
9. Namzaric
The 3 Pipeline Alzheimer’s Disease Drugs covered in the report are as follows:
1. Gantenerumab
2. Crenezumab
3. Aducanumab
The Alzheimer’s Disease Drugs Major Deals covered in the report are as follows:
1. Strategic Alliance
2. Licensing Agreement
3. Collaboration Deals
4. Mergers and Acquisitions
To know more click here -> https://www.precisemarketreports.com/report/enquiry/pmr-106497 .
About us:
Precise market reports, a one-stop research platform designed to help key decision makers and dynamic thought leaders across various industry verticals worldwide by making them aware of the past, current and future market scenario.
Tier 1's, SME's startups, top management consultants, have clearly visualized their environment using our analysis, thus enabling them to make critical business decisions and in devising a strategic plan.
Contact us:
Precise Market Reports
Office No. 48, Akshya Complex, Dhole Patil road,
Maharashtra, Pune – 411001
India.
sales@precisemarketreports.com
+1 (323) 744 6588
https://www.precisemarketreports.com
The report spread across 189 pages is an overview of the Global Alzheimer’s Disease Drugs Market, Regional Analysis & Forecast, Major Deals & Funding, and Pipeline Drugs Analysis to 2021. Alzheimer’s disease is the most common cause of dementia among older people. It is a devastating condition for those afflicted as well as their family members and caregivers; the situation is only getting worse as the population ages. With the ageing global population, the number of patients suffering from Alzheimer’s disease is predicted to grow during the forecasting period. Alzheimer's treatment is a high risk, high reward market. Drugs currently available in the market have reached maturity; patent of leading drugs have expired. The current unmet needs represent a huge opportunity for pharmaceutical companies which are developing targeted novel therapies.
Get a Sample Copy of this Report @
https://www.precisemarketreports.com/report/sample/pmr-106497 .
Global Alzheimer’s disease Drugs Market and Pipeline Drugs Analysis:
• In 2016, the global market for Alzheimer’s disease drugs was dominated by Namenda, Memary, Aricept and Exelon. The combined market share of these four drugs was over 80% in the year 2016.
• Ebixa, Razadyne/Reminyl, Rivastach and Nootropil are the other popular drugs in the Alzheimer’s disease market.
• With the patent expiration of popular drugs the sales of the Alzheimer’s drugs have also declined. However, there are several pipeline drugs like Gantenerumab, Crenezumab and Aducanumab among others which are likely to hit the market during the period 2019 - 2020.
Global Alzheimer’s Disease Country Wise Analysis:
• In the Alzheimer’s disease drugs market, the United States is the largest market.
• The EU5 countries together accounted for over 10% share of the global Alzheimer’s disease drugs market in 2016.
To Purchase this report visit @
https://www.precisemarketreports.com/paypal/checkout/pmr-106497 .
The Alzheimer’s Disease Drugs Market has been analyzed from 8 View Points:
1. Alzheimer’s Disease - Drugs Sales and Forecast
2. Alzheimer’s Disease - Pipeline Drugs Sales Forecast
3. Alzheimer’s Disease Drugs - Country Wise Market and Forecast
4. Alzheimer’s Disease - Country Wise Prevalence and Forecast
5. Alzheimer’s Disease – List of Pipeline Drugs in Various Phase of Development
6. Alzheimer’s Disease - Major Deals in Alzheimer’s Drugs Market
7. Alzheimer’s Disease - Funding in Alzheimer’s Disease Research
8. Alzheimer’s Disease Drugs Market – Driving Factors & Challenges
The Top 9 Alzheimer’s Disease Drugs covered in the report are as follows:
1. Exelon
2. Razadyne/Reminyl
3. Memary
4. Ebixa
5. Aricept
6. Rivastach
7. Namenda
8. Nootropil
9. Namzaric
The 3 Pipeline Alzheimer’s Disease Drugs covered in the report are as follows:
1. Gantenerumab
2. Crenezumab
3. Aducanumab
The Alzheimer’s Disease Drugs Major Deals covered in the report are as follows:
1. Strategic Alliance
2. Licensing Agreement
3. Collaboration Deals
4. Mergers and Acquisitions
To know more click here -> https://www.precisemarketreports.com/report/enquiry/pmr-106497 .
About us:
Precise market reports, a one-stop research platform designed to help key decision makers and dynamic thought leaders across various industry verticals worldwide by making them aware of the past, current and future market scenario.
Tier 1's, SME's startups, top management consultants, have clearly visualized their environment using our analysis, thus enabling them to make critical business decisions and in devising a strategic plan.
Contact us:
Precise Market Reports
Office No. 48, Akshya Complex, Dhole Patil road,
Maharashtra, Pune – 411001
India.
sales@precisemarketreports.com
+1 (323) 744 6588
https://www.precisemarketreports.com
Contact Information:
Precise Market Reports
Parag Pingale
Tel: +1 (323) 744 6588
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Precise Market Reports
Parag Pingale
Tel: +1 (323) 744 6588
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results